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Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term, 
debilitating condition that impacts numerous areas of individuals’ lives. The two predominant 
treatment options for ME/CFS are cognitive behavioral therapy and graded exercise therapy; 
however, many people have found these techniques unacceptable or even damaging. This pilot 
study aimed to evaluate the utility of a specialized online symptom management program for 
ME/CFS in comparison to an online meditation program in an effort to ascertain whether this 
tool could be a further option for those with ME/CFS.
Methods: This experimental design consisted of two interventions: a specialized online symp-
toms management program (N=19) and a control intervention based on an online meditation 
website (N=9). A battery of questionnaires, including measures of multidimensional fatigue, 
illness-specific symptoms, perceived control, and mindful awareness, were completed before 
the participants commenced use of the programs and following 8 weeks’ use.
Results: Significant differences were found in the areas of chance and powerful others’ locus 
of control, and sleeping difficulties, but not in ME/CFS symptomatology overall.
Conclusion: The specialized online program described in this study warrants further investiga-
tion, as it appears to influence perceived control and key ME/CFS symptoms over time.
Keywords: ME/CFS, perceived control, sleep, outcomes, online intervention
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a condition char-
acterized by severe and often debilitating fatigue, postexertional malaise, sleep distur-
bance, and autonomic, neuroendocrine, and immune manifestations.1 Epidemiological 
studies have produced varying rates of prevalence of this disorder from 3 to 2,800 per 
100,000,2–8 which is perhaps reflective of the difficulties in defining ME/CFS. Indeed, 
in one epidemiological study, rates varied from 0.03%–0.19% when using different 
diagnostic case criteria.8 Variation also exists in terms of whether ME/CFS has been 
self-reported or clinically assessed; a recent meta-analysis calculated pooled prevalence 
rates of 3.28% and 0.76%, respectively.9 However, what is apparent is that this condi-
tion, whether self-identified or diagnosed objectively, is highly intrusive into individu-
als’ lives, often disrupting work, interpersonal relationships, and previously enjoyed 
recreational activities.10 In addition, ME/CFS has a substantial impact on the wider 
economy; the average cost in treatments, lost income, and benefit payments was found 
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to be £3,515 per individual with ME/CFS over a 3-month 
period.11 Therefore, there appears to be a clear rationale for 
finding effective, long-term treatments for ME/CFS.
In the UK, current guidelines from the National Institute 
for Health and Care Excellence suggest that cognitive behav-
ioral therapy (CBT) and graded exercise therapy (GET) should 
be offered to those with ME/CFS.12 These suggestions are 
based on a body of evidence that shows CBT and GET to 
be effective treatment options.13–15 However, these studies 
included only the mildly and moderately affected, not house- 
and bed-bound individuals, and often had high drop-out rates; 
hence, how far this data can be generalized is questionable. 
The recent PACE trial in the UK, which compared CBT and 
GET to standard medical care and adaptive pacing therapy 
(APT), found the former techniques to be more effective.15 
Twenty-two percent of those in the CBT arm of the trial, 22% 
within the GET group, 8% who received APT, and 7% who 
engaged in standard medical care only were reported to have 
recovered following this multicenter trial.16
However, recent surveys by two of the largest charities 
in the UK, the ME Association and Action for ME, found a 
rather different picture to that of the aforementioned studies. 
Regarding GET, in a survey of 906 respondents, 33.1% said 
that they were “much worse” after the treatment, 23.4% said 
they felt slightly worse, 21.4% reported no change in symp-
toms, 18.7% stated that they improved, and 3.4% felt they 
had improved greatly.17 Similarly, Action for ME found that 
22.2% of participants felt they had improved following GET, 
although 60.2% of respondents in the survey said it had made 
their condition worse, of which 44.1% reported much or very 
much worse symptomatology.18 These data should of course 
be viewed with caution, as these surveys could contain bias, 
but these results are useful in gaining an understanding of 
why some participants may have dropped out of GET trials, 
as it can be difficult to gauge this in randomized controlled 
trials (RCTs) if harms are not documented.19
In the face of unacceptable treatment options, many people 
turn to complementary and alternative medicine (CAM). In 
a study of comparable CAM use in twin pairs discordant for 
ME/CFS, 91% of those with the condition had engaged in 
a CAM technique, whereas 71% of the non-ME/CFS twins 
had used CAM in their lifetime.20 Eighty-one percent of 
the twins with ME/CFS found these therapies helpful. In a 
systematic review of CAM techniques used in the treatment 
and management of ME/CFS,21 it was found that in 60 of 
the 70 studies reviewed, 86% reported at least one positive 
effect (treatments ranged from supplementation to medita-
tive practices). Fifty-two studies also found improvement in 
 illness-related symptoms (74%).21 In a slightly more recent 
review of 26 RCTs, evidence was found for the effectiveness 
of these various approaches in ME/CFS symptom alleviation.22 
Hence, the literature that suggests nonorthodox perspectives 
could be useful for the management of ME/CFS.
Online therapy has become increasingly popular for a range 
of conditions, including anxiety and depression,23–25 panic 
disorder,26–28 post-traumatic stress disorder,29 addictions,30 
irritable bowel syndrome,31 and other conditions such as 
stress, insomnia, and eating disorders.32 In terms of ME/CFS, 
a recent RCT of 135 adolescents with the condition made 
comparisons between an internet-based therapeutic program 
and usual care.33 Significant differences were found on mea-
sures of school attendance, fatigue, and overall functioning at 
6 months, with those participants who engaged in the online 
program achieving better outcomes. Hence, there appears to 
be promise in the utility of newly developed, tailored online 
programs for ME/CFS.
This pilot study aimed to evaluate the utility of an online 
symptom management program that has been specifically 
designed for people with ME/CFS. This program is part of an 
integrated medicine approach to the treatment of ME/CFS,34 
which has recently been investigated in terms of general 
health outcomes, multidimensional fatigue measures, ME/
CFS-specific symptoms, and perceived control.35 The results 
of this study showed promise, as participants improved sta-
tistically significantly from baseline to 3-month follow-up in 
fatigue, functional ability, and ME/CFS symptomatology. 
However, as the participants in this preliminary prospective 
study had additional psychological, nutritional, or combined 
support, it was not possible to elucidate the contribution of the 
online symptom management program on its own. Therefore, 
this study compared the ME/CFS online symptoms manage-
ment program to online meditation guidance by examining 
self-reports of multidimensional fatigue, illness-specific symp-
toms, and perceived control at baseline and 8-week follow-up. 
An evaluation of mindful awareness was also included, as the 
control intervention was based on meditation principles.
Perceived control has been shown to be an important 
factor in ME/CFS. In Vercoulen et al’s empirical model of 
the behavioral, cognitive, and affective factors involved in 
this condition, perceived control had a direct causal effect 
on fatigue.36 In prospective work, internal locus of control 
has been found to be negatively correlated with standardized 
functional impairment, but not fatigue severity or change 
scores, in those with ME/CFS.37 However, the remaining 
dimensions of locus of control (chance and powerful others) 
were not associated with outcomes. Hence, individuals with 
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ME/CFS who had a sense that they could control their illness 
and symptomatology had less overall impairment (work, 
home management, social and leisure activities) 1 year from 
initial assessment.37 However, other studies have shown that 
participants who believed that the control of their condition 
was the responsibility of others, particularly doctors, had 
poorer psychological adjustment.38
Therefore, it was hypothesized that:
1. The experimental intervention will significantly decrease 
fatigue and illness-specific symptoms in comparison to 
the control intervention;
2. The experimental intervention will significantly increase 
internal locus of control and decrease beliefs in chance 
and powerful others in comparison to the control 
intervention;
3. Both the experimental and control conditions will increase 
mindful awareness.
Methods
study design and ethics
The study was a between-participants experimental design, 
with participants allocated to an experimental or control 
intervention. Both interventions were online support pro-
grams, one designed specifically for ME/CFS and one generic 
meditation site. Participants completed a battery of measures 
before commencing use of the online programs and 8 weeks 
later in order to gauge intervention effects.
experimental intervention
The Optimum Health Clinic Foundation (OHCF; registered 
charity number 1131664) is a charity that offers psycho-
logical and nutritional therapies for people with ME/
CFS. The founder and CEO of this clinic, with assistance 
from the team at OHCF, developed an online symptom 
management program known as “Secrets to Recovery”. 
The program was created based on the team’s personal 
experience of ME/CFS, extensive work with individuals 
with this condition, and personal research efforts by the 
CEO. This tool is privately owned by Alex Howard and 
Associates Ltd and licensed to the charity per client. This 
program is formatted so that the user is able to focus on a 
variety of self-help areas in their everyday lives. It aims to 
help and alleviate a number of physical and psychological 
symptoms by using a combination of clinician advice, ME/
CFS patient success stories for support and encouragement, 
and taught activities which can be performed at home. 
The program is not rigid; users can spend long or short 
time spans on whichever areas they choose. But there is 
a slight level of order and structure, as the program is set 
into 15 main modules:
•	 Module 1: Coaching Yourself for Recovery
•	 Module 2: Psychology Essentials
•	 Module 3: Nutrition Essentials
•	 Module 4: Meditation Essentials
•	 Module 5: Emotional Freedom Technique (EFT) 
Essentials
•	 Module 6: Nutrition – Basic Supplements
•	 Module 7: Meditation and Breathing
•	 Module 8: Working with your Emotions
•	 Module 9: Advanced EFT
•	 Module 10: Pacing and Preventing Relapse
•	 Module 11: Nutrition – Healthy Cooking Basics
•	 Module 12: Conscious Transformation
•	 Module 13: EFT Sessions
•	 Module 14: Advanced Meditation Skills
•	 Module 15: Neuro-linguistic programming (NLP) Tools 
for Recovery (http://www.secretstorecovery.com/). 
control intervention
An online program that utilized a type of meditation in the 
form of a basic relaxation exercise was selected as a control 
intervention. This particular site was chosen as it also con-
tains a number of phases or stages, and so is comparable to 
the experimental intervention. The control online program 
provides a plan for basic relaxation, divided into a five-step 
technique, which can be followed at home and gradually built 
upon. The five stages are as follows:
•	 Stage 1 is practicing deep breathing meditation for stress 
relief;
•	 Stage 2 is progressive muscle relaxation for stress 
relief;
•	 Stage 3 is a body scan meditation for stress relief;
•	 Stage 4 is mindfulness for stress relief;
•	 Stage 5 is visualization meditation for stress relief.
The instructions also contain useful advice for the 
best places and times of day to partake in basic relaxation 
(http://helpguide.org/mental/stress_relief_meditation_yoga_ 
relaxation.htm). 
ethics
The study was granted ethical approval by the University of 
East London’s Research Ethics Committee. Participants were 
informed in their “Invitation to Participate” that they maintained 
the right to withdraw from the study at any point during the 
process. All participants signed consent forms before embark-
ing on the study, after reading about the study’s purpose, aims, 
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and objectives, and what would be required for participation. 
Participants were made aware that any data or correspondence 
received from them during any part of the study would remain 
confidential and would only be viewed by those researchers 
involved in the study. All data files were fully anonymized, 
with personal correspondence information kept in separate, 
password-protected files, or in locked cabinets if hard copies. 
At the end of the study, participants were debriefed and given 
the opportunity to ask any questions regarding the project. The 
participants were not deceived at any point during the study, 
and were able to participate from their own homes.
Participants
Participants were recruited though local ME/CFS support 
groups across the UK. Email addresses for support group 
leaders were sourced from the Action for ME website; leaders 
were then subsequently emailed relevant study information 
which was passed onto group members. Contact details were 
given for the research team so that potential participants 
could either ask questions about the study and/or register 
their interest in participating. For those who volunteered, 
further information and a consent form were either emailed 
or posted to the participant. Hence, informed consent was 
obtained when the participants signed the consent forms and 
posted them back to the research team.
In total, 30 individuals were recruited into the study; 
however, two participants (6.66%) withdrew from the study 
due to deteriorating health and personal issues which pre-
vented their use of the intervention. Both drop-outs had been 
assigned to the experimental group and were severely affected 
in terms of their Bell’s CFS Disability Scale score.39 One was 
the oldest participant, recruited at 72 years of age with an 
illness duration of 19 years, scoring 10 on the Bell’s Scale, 
which equates to the following description: “Severe symp-
toms at rest; bedridden the majority of the time. No travel 
outside of the house. Marked cognitive symptoms preventing 
concentration.” The second participant to withdraw from the 
study was 31 years old, with an illness duration of 4 years, 
who scored 10 on the Bell’s scale. This is a notable finding, 
as these were the only two participants in the study to score 
this severely on the disability scale. Both participants cited 
a sudden illness onset. It should be considered that these 
individuals told the research team that they found the process 
of completing the prequestionnaires quite arduous; therefore, 
thought should be given for future studies when recruiting 
the severely affected to ensure that the burden on this group 
is not overly high and also to find ways to make it possible 
for severely affected people to take part in research.
Inclusion criteria for this study were a self-reported 
diagnosis of ME/CFS and age of 18 years or more. Exclusion 
criteria included previous or current experience of the OHCF 
programs, although no one who volunteered for this study 
reported this.
Materials
The questionnaires chosen for this study were selected to 
encompass various areas of illness experiences in those with 
ME/CFS, including illness-specific symptoms, perceived 
control, different types of fatigue, and mindful awareness.
Bell’s cFs Disability scale
The Bell’s CFS Disability Scale is used by doctors to assess 
the severity of ME/CFS symptomatology, the degree of activ-
ity impairment with both activity and rest, and  functional 
ability regarding full-time work and daily tasks.39 The 
disability  rating scale which has been developed is graded in 
boundaries of ten ranging from 100 (no symptoms at rest, no 
symptoms during exercise and a normal activity level) to 0 
(severe symptoms, bedridden constantly, and unable to care 
for one’s self). This measure was used at baseline only for 
characterization purposes.
Multidimensional health locus of control scale
Locus of control refers to individuals’ beliefs regarding 
the extent to which they feel they are able to control or 
influence outcomes. The Multidimensional Health Locus 
of Control Scale (MHLC) focuses on whether individuals 
see control as either residing mainly in themselves, or 
elsewhere.40 The scale consists of 18 items over three sub-
scales: “internal”, “chance”, and “powerful others”, which 
has two dimensions, that of “doctors” and “other people”. 
There are six items each for the internal and chance scales 
and three items for both powerful others scales, which are 
scored on a 6-point Likert scale from “strongly agree” to 
“strongly disagree”. Cronbach’s alpha coefficients range 
from 0.67 for powerful others to 0.77 for internal, which 
illustrates good internal reliability of the measure. In terms 
of convergent validity, the instrument correlates positively 
and significantly with associated scales from Levenson’s 
locus of control measure41 from which the MHLC was 
based.40
Multidimensional Fatigue inventory
The Multidimensional Fatigue Inventory (MFI) is a self-
report instrument consisting of 20 items devised to mea-
sure a broad spectrum of fatigue.42 It includes five distinct 
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dimensions: general fatigue, physical fatigue, mental fatigue, 
reduced motivation, and reduced activity. The 5-point scale 
gives options ranging from “yes, that is true” to “no, that is 
not true” in response to items such as “I tire easily”. Lower 
scores on this instrument reflect higher levels of fatigue. 
The internal consistency of the MFI is good, with average 
Cronbach’s alpha coefficient of 0.84 across the five subscales. 
In a sample of radiotherapy patients, correlations between 
the subscales, and a visual analogue fatigue scale were 
0.77 for general fatigue, 0.70 for physical fatigue, 0.61 for 
reduced activity, 0.56 for reduced motivation, and 0.23 for 
mental fatigue.42
cDc cFs symptom inventory
The Centers for Disease Control and Prevention (CDC) CFS 
Symptom Inventory43 is a self-report instrument that collects 
information about the presence, frequency, and intensity of 
19 fatigue- and ME/CFS-related symptoms. The inventory 
includes eight ME/CFS defining symptoms as based on the 
CDC case definition:44 postexertional fatigue, unrefreshing 
sleep, problems remembering or concentrating, muscle 
pain, joint pain, sore throat, tender and swollen glands, and 
headaches. It also includes other accompanying symptoms 
on a six-point scale of perceived frequency (0= absent, 5= all 
the time) and severity (0= none, 5= very severe). Internal 
consistency is acceptable of this scale; the Cronbach’s alpha 
coefficient equaling 0.88. Regarding convergent validity, 
a correlation of 0.74 has been observed with the Chalder 
Fatigue Scale45 and –0.68 and –0.87 with the SF-3646 
“vitality” and “bodily pain” subscales, respectively. The 
CDC inventory has been shown to distinguish people with 
ME/CFS from people with fatigue who were not diagnosed 
with the disorder.43
Mindful attention awareness scale
The Mindful Attention Awareness Scale (MAAS) is a 
15-item scale designed to assess a core characteristic of 
dispositional mindfulness, primarily, open or receptive 
awareness of and attention to what is taking place at the 
present. MAAS taps into a level of consciousness which 
is predictive of self-regulation and well-being constructs.47 
The measure uses a 4-point Likert scale from “almost never” 
to “always”, for items such as “It seems I am ‘running on 
automatic’ without much awareness of what I’m doing.” 
In an evaluation of test-retest reliability, a correlation of 
0.81 was found, demonstrating good temporal stability. 
The MAAS also correlates significantly with a number of 
well-being measures.47
Procedure
After informed consent was received from each participant, 
the questionnaire pack was either emailed or posted to the 
participants’ homes. All participants were asked to initially 
complete the questionnaires before engaging in the online 
programs. Those within the experimental group were pro-
vided with usernames and passwords to access the symptom 
management program, whereas the control intervention was 
open-access. Participants were requested to partake in the 
programs for 8 weeks, and were advised to spend a mini-
mum of 30 minutes each day for 5 days per week using the 
material. At the end of the 8-week intervention period, both 
the experimental and control group were asked to complete 
the questionnaire pack once again.
Results
A total of 28 participants completed the 8-week study, 
25 (89.3%) of whom were female and three (10.7%) male. 
The mean age of participants was 44.43 (standard devia-
tion [SD] =13.00), and the age range was 20–68 years. The 
mean illness duration (years) for all participants was 10.89 
(SD =8.05; range 1–30 years). Eleven (39.29%) participants 
reported a sudden onset, while the remaining 17 (60.71%) 
participants stated that their illness developed gradually.
The 28 participants were assigned to the experiment group 
(19 participants), or the control group (nine participants). 
There were no significant differences in the groups in 
terms of sex (Χ2(1)=0.00, P.0.05).  However, there was 
a significant difference in terms of age, with those in the 
control group being significantly older than participants in 
the experimental group (t(26)=−2.45, P=0.021). There were 
no significant differences between the groups in fatigue 
symptomatology.
Descriptive statistics were calculated for each outcome 
variable by group (Table 1). Mean scores in all dimensions 
of fatigue were higher than both male and female norms 
for participants of similar age,48 although similar to radio-
therapy patients.42 However, the participants in this sample 
reported less fatigue than previous samples of chronically 
fatigued patients.42 Therefore, it is possible that this sample 
consisted of individuals at the higher end of the functioning 
on the ME/CFS spectrum.
To evaluate within-group change from baseline to 
follow-up, a series of related t-tests were carried out 
(Table 2). Significant differences were found from baseline 
to follow-up in the  experimental group in the mental fatigue 
dimension (t(18)=3.33, P=0.004) and in reduced motivation 
(t(18)=2.28, P=0.035). In terms of health locus of control, 
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Table 1 Descriptive statistics for experimental and control groups at baseline and follow-up
Measures Baseline Follow-up
Experimental Control Experimental Control
Mean SD Mean SD Mean SD Mean SD
MFi general fatigue 16.95 2.99 17.33 3.20 15.68 4.64 17.11 2.62
MFi physical fatigue 16.37 3.48 16.33 3.28 15.84 3.10 17.44 2.01
MFi mental fatigue 14.05 3.37 14.78 4.71 12.11 3.75 14.33 5.66
MFi reduced activity 14.47 3.73 16.89 4.08 14.47 8.44 17.11 3.02
MFi reduced motivation 11.63 4.25 12.67 3.54 9.63 2.99 12.22 3.11
Mhlc internal 0.45 0.20 0.56 0.27 0.64 0.13 0.52 0.18
Mhlc chance 0.47 0.18 0.44 0.19 0.35 0.10 0.48 0.13
Mhlc doctors 0.18 0.07 0.19 0.10 0.21 0.17 0.22 0.09
Mhlc powerful others 0.41 0.13 0.41 0.16 0.37 0.17 0.46 0.10
Mhlc other people 0.23 0.09 0.22 0.07 0.27 0.16 0.24 0.05
cDc total score 148.00 70.81 142.00 75.66 130.42 76.00 137.63 63.47
cDc depression 6.68 4.16 5.00 4.03 2.58 2.55 5.00 2.00
cDc sleeping problems 12.74 8.39 12.11 10.64 9.16 6.25 11.89 10.04
CDC difficulty concentrating 10.47 7.05 10.33 7.55 8.58 6.22 12.44 8.75
Maas 48.06 4.44 47.56 4.64 44.06 9.12 45.44 1.12
Abbreviations: cDc, centers for Disease control chronic Fatigue syndrome symptom inventory; Maas, Mindful attention awareness scale; MFi, Multidimensional 
Fatigue inventory; Mhlc, Multidimensional health locus of control scale; sD, standard deviation.
Table 2 Results of outcome measures of baseline and follow-up
Measures Groups Mean difference 95% CI Within-groups Between groups Effects 
sizedf t df F
MFi general  
fatigue
experimental 1.26 (−1.03 to 3.56) 18 1.16 1, 27 0.62 0.03
control 0.22 (−1.88 to 2.32) 8 0.24
MFi physical  
fatigue
experimental 0.53 (−1.03 to 2.09) 18 0.71 1, 27 1.37 0.05
control −1.11 (−3.01 to 0.79) 8 −1.35
MFi mental  
fatigue
experimental 1.95 (0.72 to 3.18) 18 3.33** 1, 27 0.79 0.03
control 0.44 (−2.56 to 3.45) 8 0.34
MFi reduced  
activity
experimental 0.00 (−3.81 to 3.81) 18 0.00 1, 27 0.06 0.00
control −0.22 (−1.84 to 1.40) 8 −0.32
MFi reduced  
motivation
experimental 2.00 (0.16 to 3.84) 18 2.28* 1, 27 1.14 0.05
control 0.44 (−0.65 to 1.54) 8 0.94
Mhlc internal experimental −0.18 (−0.30 to −0.07) 18 −3.39** 1, 27 3.31 0.12
control 0.04 (−0.11 to 0.19) 8 0.63
Mhlc chance experimental 0.12 (0.03 to 0.22) 18 2.64* 1, 27 8.96** 0.27
control −0.04 (−0.17 to 0.10) 8 −0.63
Mhlc doctors experimental −0.03 (−0.12 to 0.05) 18 −0.075 1, 27 0.01 0.00
control −0.03 (−0.08 to 0.03) 8 −1.20
Mhlc powerful  
others
experimental 0.04 (−0.04 to 0.12) 18 0.99 1, 27 4.42* 0.16
control −0.05 (−0.15 to 0.05) 8 −1.22
Mhlc other  
people
experimental −0.04 (−0.12 to 0.04) 18 −0.95 1, 27 0.03 0.00
control −0.03 (−0.08 to 0.03) 8 −0.97
cDc total score experimental 17.58 (−2.44 to 37.59) 18 1.85 1, 27 0.20 0.01
control 4.38 (−26.88 to 35.63) 8 0.33
cDc depression experimental 4.11 (1.76 to 6.44) 18 3.68** 1, 27 4.08 0.15
control 0.00 (−3.12 to 3.12) 8 0.00
cDc sleeping  
problems
experimental 3.58 (1.10 to 3.04) 18 3.04** 1, 27 4.99* 0.17
control 0.22 (−1.53 to1.97) 8 0.29
CDC difficulty  
concentrating
experimental 1.89 (−0.35 to 1.78) 18 1.76 1, 27 3.00 0.11
control −2.11 (−6.96 to 2.74) 8 −1.00
Maas experimental 4.00 (−0.47 to 1.89) 18 1.89 1, 27 0.03 0.00
control 2.11 (−1.11 to 5.34) 8 1.51
Notes: Means difference, 95% ci, paired t-test, ancOVa, and between-groups effect sizes. *P,0.05; **P,0.01.
Abbreviations: ANCOVA, analysis of covariance; CDC, Centers for Disease Control Chronic Fatigue Syndrome Symptom Inventory; CI, confidence interval; MAAS, 
Mindful attention awareness scale; MFi, Multidimensional Fatigue inventory; Mhlc, Multidimensional health locus of control scale.
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there were significant differences from time 1 to time 2 
within the internal subscale (t(18)=−3.39, P=0.003) and 
chance (t(18)=2.64, P=0.017), in the expected directions. 
There were also differences over time in the experimental 
group in the depression item of the CDC CFS Symptom 
Inventory (t(18)=3.68, P=0.002) and the sleeping problems 
item (t(18)=3.04, P=0.007), but not in the overall score. There 
were no significant differences in any outcome measures from 
time 1 to time 2 in the control group (Table 2).
To investigate between-group differences, scores were 
analyzed using analysis of covariance so that baseline varia-
tion in scores and age could be controlled for (the former due 
to the small sample size and unequal group numbers and the 
latter as the two groups differed significantly on this variable). 
With these covariates entered into the analysis, there were no 
significant differences in terms of multidimensional fatigue. 
Significant differences were found in chance (F(1, 27)=8.96, 
P=0.006) and powerful others (F(1, 27)=4.42, P=0.046) per-
ceived control. In the CDC CFS Symptom Inventory, a sig-
nificant difference was found in the item sleeping problems 
(F(1, 27)=4.99, P=0.035) and depression scores approached 
significance (F(1, 27)=4.08, P=0.055). The largest effect size 
was observed in chance locus of control, although this was 
small at 0.27.
Discussion
This pilot study aimed to investigate the utility of a special-
ized online symptom management program as compared to 
an online meditation program. While controlling for baseline 
measurements and age, significant differences were found 
between the groups in chance and powerful others locus of 
control and sleeping problems scores. Differences in depres-
sion across the groups approached significance. When look-
ing at the groups independently over time, it was seen that 
change occurred in the experimental group only.
It is perhaps unsurprising that group differences were 
found in the powerful others item of the perceived control 
scale, as “Secrets to Recovery” shows individuals how they 
can make changes to their lives themselves. Similarly, the 
changes in chance perceived control would appear in line 
with the aims and content of the program. These are prom-
ising findings, as it has been shown that perceived control 
impacts functional ability and psychological adjustment in 
those with ME/CFS.38
Interesting, the only ME/CFS specific symptom to 
improve across groups was sleeping problems. This certainly 
warrants further investigation, as recent studies have shown a 
range of different sleep disturbances in those with ME/CFS.49 
If the present online symptom management program can 
indeed help to rectify sleep issues, this would certainly be of 
benefit to the patient population. However, further, objective 
research would need to be conducted to corroborate these 
findings and also to uncover the mechanisms of action. 
Although there was not a significant difference across groups 
in depression, mental fatigue, or internal locus of control or 
motivation, there were differences from time 1 to time 2 in 
the experimental group. As this group was younger than the 
control group, it may be worth investigating these items in 
greater depth and perhaps tailoring the program further on 
the basis of age. Of course, additional work needs to be car-
ried out to assess why there should be differences in these 
variables; this could be another area of future research.
It is unclear why neither intervention produced changes 
in mindful awareness. Mindfulness is a progressive prac-
tice, so perhaps developing this skill requires more than an 
8-week period. It would be useful to track participant usage 
of online programs as a form of compliance in future so that 
this important factor can be accounted for.
ME/CFS is a complex disorder which impacts on the indi-
vidual, family and wider society; therefore, new and innovative 
techniques that are acceptable to people should be developed. 
Until we know the precise mechanisms of this illness, CAM 
approaches could hold potential for symptom alleviation, 
a finding that has been observed in recent reviews.21,22
As this was a pilot study, it does have limitations. The 
sample size was very small, participants were not randomly 
allocated to groups, and the groups were uneven in number; 
future work should rectify these issues. In addition, recruit-
ment was via support groups and ME/CFS diagnosis was 
self-reported; both factors could have produced a bias in 
this study. Future work should aim to recruit from a range 
of sources, including GP practice and/or specialist ME/CFS 
centers, and diagnosis should be confirmed independently.
Furthermore, it would be useful to delineate which com-
ponents of the specialized online management program were 
responsible for the present findings. There are numerous 
modules in this program, and it may be the case that some 
are more “active” than others. This could be investigated first 
with qualitative approaches exploring participants’ experi-
ences of using this tool. Alternatively, mixed methodologies 
could be used to compare some elements of the program with 
others; these studies could also contain a qualitative section 
to capture more in-depth data that may highlight differing 
experiences of the individual modules.
Although efforts were made to find a comparable online 
program to the specialized ME/CFS symptom management 
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program, due to the length and breadth of the latter, this was 
difficult; future, larger-scale work should aim to either devise 
an equivalent program or possibly combine a number of 
online resources to create an analogous tool for  comparison. 
Finally, a longer follow-up needs to take place to see if 
improvements are maintained.
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